Medtronic must face shareholder lawsuit over Infuse: U.S. appeals court

(Reuters) - A U.S. federal appeals court on Wednesday revived a lawsuit accusing Medtronic Plc of defrauding shareholders by covering up negative side effects from its Infuse bone growth product.